Cardiotoxicity evaluation of anthracyclines in zebrafish (Danio rerio)
- 22 May 2014
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 35 (3) , 241-252
Abstract
Drug‐induced cardiotoxicity is a leading factor for drug withdrawals, and limits drug efficacy and clinical use. Therefore, new alternative animal models and methods for drug safety evaluation have been given great attention. Anthracyclines (ANTs) are widely prescribed anticancer agents that have a cumulative dose relationship with cardiotoxicity. We performed experiments to study the toxicity of ANTs in early developing zebrafish embryos, especially their effects on the heart. LC50 values for daunorubicin, pirarubicin, doxorubicin (DOX), epirubicin and DOX‐liposome at 72 h post‐fertilization were 122.7 μM, 111.9 μM, 31.2 μM, 108.3 μM and 55.8 μM, respectively. At the same time, zebrafish embryos were exposed to ANTs in three exposure stages and induced incomplete looping of the heart tube, pericardia edema and bradycardia in a dose‐dependent manner, eventually leading to death. DOX caused the greatest heart defects in the treatment stages and its liposome reduced the effects on the heart, while daunorubicin produced the least toxicity. Genes and proteins related to heart development were also identified to be sensitive to ANT exposure and downregulated by ANTs. It revealed ANTs could disturb the heart formation and development. ANTs induced cardiotoxicity in zebrafish has similar effects in mammalian models, indicating that zebrafish may have a potential value for assessment of drug‐induced developmental cardiotoxicity. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Natural Science Foundation of China (No. 81173043 and 30772681)
- National S&T Major Special Project on Major New Drug Innovation (2012ZX09301002-001-021)
This publication has 49 references indexed in Scilit:
- The toxic effect of Amiodarone on valve formation in the developing heart of zebrafish embryosReproductive Toxicology, 2011
- Zebrafish as a model to study cardiac development and human cardiac diseaseCardiovascular Research, 2011
- What Has Polar Surface Area Ever Done for Drug Discovery?Future Medicinal Chemistry, 2011
- A thorough benchmark of density functional methods for general main group thermochemistry, kinetics, and noncovalent interactionsPhysical Chemistry Chemical Physics, 2011
- Comparative genomics identifies genes mediating cardiotoxicity in the embryonic zebrafish heartPhysiological Genomics, 2008
- Clinical review: Aggressive management and extracorporeal support for drug-induced cardiotoxicityCritical Care, 2007
- Adriamycin-induced oxidative mitochondrial cardiotoxicityCell Biology and Toxicology, 2006
- Aryl Hydrocarbon Receptor Activation Produces Heart-Specific Transcriptional and Toxic Responses in Developing ZebrafishMolecular Pharmacology, 2006
- Heart Malformation Is an Early Response to TCDD in Embryonic ZebrafishToxicological Sciences, 2005
- Mutation ofweak atrium/atrial myosin heavy chaindisrupts atrial function and influences ventricular morphogenesis in zebrafishDevelopment, 2003